Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/60694
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorReboredo, Mercedes-
dc.contributor.authorDe Las Rivas, Javier-
dc.date.accessioned2012-11-21T09:32:54Z-
dc.date.available2012-11-21T09:32:54Z-
dc.date.issued2008-
dc.identifierdoi: 10.1038/sj.gt.3303073-
dc.identifierissn: 0969-7128-
dc.identifiere-issn: 1476-5462-
dc.identifier.citationGene Therapy 15: 277-288 (2008)-
dc.identifier.urihttp://hdl.handle.net/10261/60694-
dc.descriptionEl pdf del artículo es la versión de autor.-- et al.-
dc.description.abstractDrug-inducible systems allow modulation of the duration and intensity of cytokine expression in liver immuno-based gene therapy protocols. However, the biological activity of the transgene may influence their function. We have analyzed the kinetics of interleukin-12 (IL-12) expression controlled by the doxycycline (Dox)- and the mifepristone (Mif)-dependent systems using two long-term expressing vectors directed to liver: a plasmid administered by hydrodynamic injection and a high-capacity adenoviral vector. Daily administration of Dox or Mif was associated with a progressive loss of inducibility and a decrease of murine IL-12 production. This inhibition occurred at the transcriptional level and was probably caused by an interferon (IFN)-γ-mediated downmodulation of liver-specific promoters that control the expression of transactivators in these systems. Genome-wide expression microarrays studies revealed a parallel downregulation of liver-specific genes in mice overexpressing murine IL-12. However, a promoter naturally induced by IL-12 was also inhibited by this cytokine when placed in a plasmid vector. Interestingly, treatment with sodium butyrate, a class I/II histone deacetylase inhibitor, was able to rescue liver-specific promoter activity solely in the vector. We conclude that biologically active IL-12 can transiently inhibit the function of drug-inducible systems in non-integrative DNA vectors by reducing promoter activity, probably through IFN-γ and protein deacetylation-dependent mechanisms.-
dc.description.sponsorshipThis project was founded through the UTE project CIMA, DIGNA Biotech and Grants from Education Department, Gobierno de Navarra and Fondo de Investigación Sanitaria (FIS) and CIBERehd. RHA is a recipient of Ramón y Cajal research contract. MGK is a recipient of an FIS research contract. IM is a recipient of a Torres Quevedo contract.-
dc.language.isoeng-
dc.publisherNature Publishing Group-
dc.rightsopenAccess-
dc.titleInterleukin-12 inhibits liver-specific drug-inducible systems in vivo-
dc.typeartículo-
dc.identifier.doi10.1038/sj.gt.3303073-
dc.relation.publisherversionhttp://dx.doi.org/10.1038/sj.gt.3303073-
dc.date.updated2012-11-21T09:32:54Z-
dc.description.versionPeer Reviewed-
dc.identifier.pmid18033307-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.fulltextWith Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeartículo-
item.grantfulltextopen-
item.languageiso639-1en-
Aparece en las colecciones: (IBMCC) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
INTERLEUKIN-12.pdf3,33 MBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

PubMed Central
Citations

5
checked on 25-abr-2024

SCOPUSTM   
Citations

16
checked on 23-abr-2024

WEB OF SCIENCETM
Citations

15
checked on 23-feb-2024

Page view(s)

356
checked on 23-abr-2024

Download(s)

328
checked on 23-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.